Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
暂无分享，去创建一个
A. Alizadeh | Y. Natkunam | C. Liu | D. Kurtz | J. Schroers-Martin | M. Jin | M. Diehn | D. Miklos | B. Sahaf | A. Hüttmann | U. Dührsen | C. Mackall | M. Khodadoust | J. Westin | S. Beygi | H. Hosoya | B. Sworder | R. Majzner | Mari N. Olsen | S. Alig | Andrea Garofalo | Mia Carleton | M. Frank | J. Spiegel | N. Sheybani | J. Oak | S. Younes | Navika D. Shukla | Mark Hamilton | T. Sugio | C. Hanoun | C. Macaulay | A. Craig | Mohammad Shahrokh Esfahani | James Hamilton | John H. Baird | John H Baird | A. Garofalo | M. Olsen | J. Hamilton | J. Baird